Sleep Apnea Overview and Management

Sleep Apnea

Chapter 32

  • Page 472
Can Sleep Apnea Go Away?
  • Sleep apnea is a chronic condition that results from anatomical factors and therefore does not resolve on its own.
Treatment Options
  • Treatments include:
      - Treating allergies
      - Jaw surgery
      - Circular breathing techniques
      - Weight loss
      - Continuous Positive Airway Pressure (CPAP) therapy

  

Normal Sleep Stages

  • Individuals cycle through two major sleep stages during normal sleep:
      - Non-Rapid Eye Movement (Non-REM) Sleep:
        - Also known as quiet or slow-wave sleep.
      - Rapid Eye Movement (REM) Sleep:
        - Also known as active or dreaming sleep.

  

Electroencephalographic Patterns in Sleep Stages

Characteristic Patterns:

  • Each stage of sleep is associated with unique electroencephalographic (EEG), behavioral, and breathing patterns:
      - Stage W: (Eyes open – wake)
        - Beta waves
      - Drowsy: (Eyes closed – wake)
        - Alpha waves
      - Non-REM Sleep:
        - Stage N1: (Light sleep)
          - Theta waves
        - Stage N2: (Light sleep)
          - K complexes, vertex waves
        - Stage N3: (Slow wave sleep)
          - Delta waves
        - Stage N3: (Deep sleep)
          - Delta waves
      - REM Sleep:
        - Sawtooth waves

  

Non-REM Sleep Characteristics

  • Non-REM sleep generally starts immediately when an individual falls asleep and comprises four distinct stages progressing into deeper sleep:
      - N1 and N2 Stages:
        - Ventilatory rate and tidal volume fluctuate, with brief periods of apnea noted.
      - N3 Stage:
        - Ventilation becomes slow and regular.
  • EEG during non-REM sleep reveals increased slow-wave activity and loss of alpha rhythm.
      - Cheyne-Stokes respiration may be common in older males during non-REM sleep, especially in high-altitude environments.
  • Non-REM sleep typically lasts from 60 to 90 minutes per cycle.

  

REM Sleep Characteristics

  • REM sleep features rapid bursts of alpha rhythms on the EEG and rapid, shallow ventilatory patterns.
  • Sleep-related hypoventilation and apnea commonly occur during this stage, with normal adults experiencing apneic episodes up to five times per hour.
  • Apneas can last between 15 to 20 seconds without apparent effects.
      - Infants may experience shorter apneas, around 10 seconds, which could still be concerning.
      - There is also a marked reduction in hypoxic and hypercapnic ventilatory responses.
  • The heart rate becomes irregular, and the eyes move rapidly during REM sleep.
  • Dreaming occurs mainly in REM sleep and is accompanied by profound atonia (muscle paralysis) affecting:
      - Arms
      - Legs
      - Intercostal muscles
      - Upper airway muscles
      - Diaphragm remains active
  • REM sleep makes up about 20% to 25% of total sleep time.

  

Types of Sleep Apnea

  • Apnea Definition:
      - Defined as cessation of breathing for a duration of 10 seconds or more.
      - Diagnosis of sleep apnea occurs if a patient has more than 5 episodes per hour over a 6-hour period, with episodes occurring in either non-REM or REM sleep.
  • Apneic episodes are typically more frequent and severe during REM sleep and in the supine position.
Episodes of Apnea
  • Apneas may last longer than 10 seconds, with severe cases exceeding 100 seconds per episode.
  • Patients with severe sleep apnea may experience over 500 episodes of apnea each night.
  • Sleep apnea can affect all age groups, and in infants, it contributes to sudden infant death syndrome (SIDS).

3 Types of Sleep Apnea

  1. Obstructive Sleep Apnea (OSA)
  2. Central Sleep Apnea (CSA)
  3. Mixed Sleep Apnea
  4. Sleep-Related Hypoventilation/Hypoxemia Syndromes
  • OSA is the most common type of sleep apnea.

  

Obstructive Sleep Apnea (OSA)

  • OSA is caused by an anatomic obstruction of the upper airway while ventilatory efforts continue.
  • During obstruction, patients may appear quiet, holding their breath, followed by desperate inhalation efforts.
      - A distinctive sound called "fricative breathing" may be heard at the end of apneic periods.
  • In severe cases, patients may suddenly awaken, sit upright, and gasp for air, a phenomenon referred to as confusional arousals.
  • While awake, patients with OSA exhibit normal and regular breathing patterns.
  • Many OSA patients showcase symptoms akin to the Pickwickian syndrome, based on a character from Charles Dickens, Joe, "the fat boy," who displayed excessive daytime sleepiness and snoring features characteristic of the sleep apnea syndrome.
      - Notably, many patients with sleep apnea are not obese.

  

Risk Factors for OSA

  • Significant risk factors include:
      - Excessive weight
      - Neck size
      - Hypertension
      - Anatomical narrowing of the upper airway
      - Chronic nasal congestion
      - Diabetes
      - Male sex
      - Age over 65 years
      - Age under 35 years with Black, Hispanic, or Pacific Islander heritage
      - Menopause
      - Family history of sleep apnea
      - Use of alcohol, sedatives, or tranquilizers
      - Smoking

  

Signs and Symptoms of OSA

  • Symptoms may include:
      - Loud snoring
      - Observed episodes of breath cessation during sleep
      - Abrupt awakenings with shortness of breath
      - Insomnia
      - Awakening with a dry mouth or sore throat
      - Morning headaches
      - Excessive daytime sleepiness (hypersomnia)
  • Mallampati Classification Score for Upper Airway Anatomy:
      - Class 1: Soft palate, fauces, uvula, pillars visible
      - Class 2: Soft palate, fauces, some of the uvula visible
      - Class 3: Soft palate and base of the uvula visible
      - Class 4: Only the hard palate visible

  

Central Sleep Apnea (CSA)

  • CSA occurs when respiratory centers in the medulla fail to send signals to respiratory muscles, resulting in:
      - Cessation of airflow at the nose and mouth
      - Cessation of inspiratory efforts (i.e., lack of diaphragmatic movement)
  • Distinct from OSA, CSA lacks marked inspiratory efforts during apneic periods.
  • CSA is associated with various cardiovascular, metabolic, and central nervous system disorders.
      - Diagnosis requires excessive apnea or hypopnea episodes (more than 30 in a 6-hour period).

Clinical Disorders Associated with CSA

  • Most common disorders:
      - Hyperventilation-related conditions
      - Cheyne-Stokes breathing pattern
      - Congestive heart failure
      - High-altitude periodic breathing
  • Hypoventilation-related conditions:
      - Secondary problems often related to underlying conditions, including:
        - Encephalitis
        - Brain stem neoplasms
        - Brain stem infarctions
        - Spinal surgery
        - Hypothyroidism
        - Drug or substance abuse, including alcohol and various sedatives

  

Mixed Sleep Apnea

  • Mixed sleep apnea consists of both obstructive and central apneas.
  • It typically starts with central apnea followed by obstructive apnea (absence of airflow despite ventilatory efforts).
  • Patients primarily classified with mixed apnea are treated as having OSA.

  

Diagnosis of Sleep Apnea

  • Diagnosis involves a thorough history from the patient or bed partner, focusing on:
      - Presence of snoring
      - Sleep disturbances
      - Persistent daytime sleepiness
  • A careful upper airway examination and possibly pulmonary function tests (PFTs) are conducted.
  • Blood analysis checks for:
      - Polycythemia
      - Reduced thyroid function
      - Bicarbonate retention
  • Arterial blood gases (ABG) evaluate resting oxygenation and acid-base balance.
  • When applicable, a carboxyhemoglobin level should be measured.
  • Diagnostic imaging, such as chest X-rays and echocardiograms, are beneficial for evaluating pulmonary hypertension and heart conditions.
Confirming Diagnosis and Type of Sleep Apnea
  • Multichannel polysomnographic sleep studies evaluate:
      - Sleep stages
      - Electroencephalogram (EEG) for brain activity
      - Electrooculogram (EOG) for eye movement and sleep stages
      - Electromyogram (EMG) for muscle activity
      - Chest and abdominal movement
      - Airflow (nasal and oral)
      - Presence of snoring
      - Oxygen saturation
      - Electrocardiogram (ECG)

  

Clinical Data for Sleep Apnea

  • Data may include:
  • Apnea or hypopnea events
  • Cyanosis
  • PFT findings—typically restrictive pathophysiology noted in obesity and congestive heart failure (CHF)
  • Often, CXR findings are normal, but right or left-sided heart failure may be present.

  

Cardiac Arrhythmias Associated with Sleep Apnea

  • Brady-tachy syndrome
  • Sinus arrhythmia
  • Sinus bradycardia
  • Sinus pause
  • Atrioventricular (AV) block (second degree)
  • Premature Ventricular Contractions (PVCs)
  • Supraventricular Tachycardia (SVT)
  • Ventricular tachycardia
  • Atrial fibrillation (A-fib)

  

Management of Obstructive Sleep Apnea

  • The most common and effective treatment for OSA is the use of CPAP (Continuous Positive Airway Pressure).
  • Role of CPAP:
      - Prevents the collapse of hypotonic and obstructed airways.
      - It’s considered the standard treatment for most OSA cases.
  • CPAP titration polysomnogram (PSG) is conducted in a sleep disorder laboratory to establish the lowest required CPAP pressure to maintain airway openness.
Therapeutic Strategies for OSA
  • Behavioral modifications:
      - Weight loss and exercise
      - Sleep position adjustments (condition worsens in the supine position)
      - Avoiding alcohol and certain sedative medications (e.g., benzodiazepines, opiates).
  • Potential surgeries include:
      - Uvulopalatopharyngoplasty (UPPP)
      - Laser-assisted uvulopalatoplasty (LAUP)
      - Mandibular advancement surgery

  

Management of Central Sleep Apnea

  • Adaptive servo-ventilation and Variable Positive Airway Pressure (VPAP) are used to provide ventilatory support for CSA, mixed apnea, and periodic breathing (e.g., Cheyne-Stokes respiration).
  • The ResMed VPAP Adapt SV adjusts pressure support in response to apneas, calculating target ventilation and required pressure to keep the airway open.
Therapeutic Strategies for CSA
  • VPAP – variable positive airway pressure adaptation
  • Phrenic nerve pacemaker
  • Drug therapies include:
      - Protriptyline (Vivactil)
      - Acetazolamide (Diamox)

  

Other Treatments for Sleep Apnea

  • Oxygen therapy
  • Pharmacologic Therapy:
      - Respiratory stimulants such as:
        - Acetazolamide
        - Theophylline
  • Medication details:
      - Acetazolamide
        - 250 mg tablets
      - Theophylline Extended-Release
        - 300 mg tablets
        - NDC: 50111-459-01
        - Rx only.
  • Prescribing information:
  • Note regarding prescribing and medical considerations for treatment.